Study Highlights Diagnostics Lag in Advancing New Therapies
A study by researchers from the University of California San Francisco (UCSF) highlights a significant lag in the development of diagnostics compared to therapeutics, due to policy gaps and payment barriers. The study, published in Science, points out that diagnostics receive lower investment and insurance coverage than drugs, creating a disincentive for their development. This misalignment affects the ability to effectively use new therapies, as seen in conditions like obesity, diabetes, and Alzheimer's disease, where diagnostics are crucial for guiding treatment decisions. 
